Notice Concerning Issuance of New Shares through Third-Party Allotment associated with Continuation of Stock Grant System for Company Group Management in Japan in Fiscal 2021
Continuation of the Stock Compensation Plan for Directors and the Stock Grant System for Company Group Management in Japan in Fiscal Year 2021
Takeda Proposes Partial Amendment to the Articles of Incorporation
Difference between Forecast and Actual Results for the Fiscal Year Ended March 2021
Takeda Delivers Resilient FY2020 Results with Strong Margins & Robust Cashflow; Underlying Revenue Growth Expected to Accelerate in FY2021
SEE ALL NEWS AND RELEASES >
・For Shire news releases, click here
Understanding the Role of Orexin in Sleep and Wakefulness
Exploring New Paths in Narcolepsy
Spotlight Malawi: Many Paths Towards Universal Health Coverage and a Strong Health Workforce
Guided by Our Values: Supporting Global COVID-19 Response
A ‘Swiss Cheese’ Approach Can Give Us a Second Chance to Contain COVID-19
SEE ALL FEATURED TOPICS ARTICLES >
With this new original series featured in Asahi Shimbun Globe, President & CEO Christophe Weber gives his unique perspective on what he has learned from his upbringing in France and his international career.
For media inquiries or reporter requests for more information, contact our Corporate Communications via Media_Relations@takeda.com. If you generally would like to contact us, please visit Contact Us.
Copyright 1995-2021 Takeda Pharmaceutical Company Limited. All rights reserved.